Maito, Jemma .
HRN: 03-62-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2023
CEFUROXIME 1.5GM (VIAL)
09/06/2023
09/12/2023
IVT
1.5g
Q8
Uti
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes